ENTITY
SMARTSCORE: 3.8/5
3SBio Inc

3SBio Inc (1530 HK)

125
Analysis
Health CareChina
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
bullish3SBio Inc
21 Jul 2025 23:18

3SBio (1530 HK): Global Index Inclusion as Stock Soars

3SBio could be added to a global index in August. There is large positioning in the stock, but industry momentum could lead to further upside in...

Logo
458 Views
Share
bullish3SBio Inc
01 Jul 2025 00:30

3SBio Inc (1530 HK): Licensing Deal a Market Hit; Will It Continue?

​3SBio signed $6B outlicensing deal with Pfizer for SSGJ-707, resulting in spectacular rally in 3SBio shares. Global trial initiation of SSGJ-707...

Logo
189 Views
Share
28 Jul 2025 00:53

What Happens to China Healthcare? - The Soaring Shares, the Turning Point, and the Top Picks

Hengrui has entered into agreements with GSK for HRS-9821 and up to 11 programs, with high upfront payment of US$500 million and total amount of...

Logo
409 Views
Share
bullish3SBio Inc
27 Mar 2025 11:51Broker

3SBio (1530 HK) - Earnings Beat, Rich Pipeline Promises Future Growth

3SBio delivered a strong performance in 2024. Revenue increased 16.5% YoY to RMB9.1bn, exceeding our estimates by 3.3%, driven by the continued...

Logo
216 Views
Share
27 Jul 2025 02:10

HK Short Interest Weekly: Kuaishou, Cspc Pharma, Galaxy Ent, ABC

We analyzed the latest HK SFC report for aggregate short position as of Jul 18th and highlight short interest changes in Kuaishou, Cspc Pharma,...

Logo
296 Views
Share
x